• Info
  • Insider Ownership

Insider Trading & Ownership of Avery W. Catlin

Location
Hingham, MA
Summary
The estimated net worth of Avery W. Catlin is at least $387,532 dollars as of 03 Jun 2024. Avery W. Catlin is the Director of Provention Bio, Inc. and owns shares of Provention Bio, Inc. stock worth about $243.2K. Avery W. Catlin is the Director of Corbus Pharmaceuticals Holdings, Inc. and owns shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock worth about $144.3K.
Signature
/s/ Meghan Houghton, attorney-in-fact for Avery Catlin
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Avery W. Catlin and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Avery W. Catlin has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $387,532.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Provention Bio, Inc. ($243,200).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Avery W. Catlin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PRVB Provention Bio, Inc. Director $243,200 27 Apr 2023
CRBP Corbus Pharmaceuticals Holdings, Inc. Director $144,332 30 May 2024

Insider Transactions Reported by Avery W. Catlin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored